Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection.

Trial Profile

Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs Linezolid (Primary)
  • Indications Bacterial infections; Osteomyelitis; Soft tissue infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Nov 2016 Status changed from recruiting to completed.
    • 04 Jul 2012 Company added in the association field as reported by EudraCT.
    • 27 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top